Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318

By afschroeder • February 27, 2026

Tian S, Su R, Wu K, Zhou X, Vadgama JV, Wu Y. Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318. J Pers Med. 2026 Feb 9;16(2):101. doi: 10.3390/jpm16020101. Erratum for: J Pers Med. 2022 Aug 16;12(8):1318. doi: 10.3390/jpm12081318. PMID: 41745417; PMCID: PMC12941905.

Tags: General Internal Medicine, King Drew Med Ctr, Publications

Association of Subclinical Cardiac Remodeling With Incident Cancer in the MESA Cohort

Cai X, White Q, Juarez J, Chehab O, Ambale-Venkatesh B, Johnson WC, Hansen SL, Inoue K, Lima JAC, Watson KE, McClelland RL. Association of Subclinical[...]

Serious health-related suffering in children and paediatric palliative care – Authors’ reply

Downing J, Knaul FM, Radbruch L, Kwete XJ, Bhadelia A. Serious health-related suffering in children and paediatric palliative care - Authors' reply. Lancet Child Adolesc[...]

Discovery of Endothelial Cell Antibodies Associated with Pediatric and Adult Kidney Allograft Rejection and Assessment of a non-HLA Antibody Assay

Butler CL, Hickey MJ, Pearl MH, Zheng Y, Gjertson D, Sunga G, Chen L, Vangala S, Elashoff D, Weng P, Lum E, Bunnapradist S, Abdalla[...]